QLGN - Qualigen Therapeutics Inc
4.21
0.010 0.238%
Share volume: 11,533
Last Updated: Wed 22 Jan 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.37%
PREVIOUS CLOSE
CHG
CHG%
$4.20
0.03
0.01%
View ratios
Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
Report Date | 2024-07-02 | 2023-08-14 | 2023-11-14 | 2024-11-14 | 2024-07-02 | 2024-08-14 | 2024-11-14 | |
Cash flow financing | 0.000 | 0.000 | -440.000 K | -110.000 K | 475.000 K | 1.150 M | 3.319 M | |
Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 265.981 K | |
Cash flow | -2.832 M | 0.000 | 4.717 M | -5.546 M | -308.586 K | 25.468 K | 269.467 K | |
Net income | -4.107 M | -3.508 M | -3.695 M | 0.000 | -2.033 M | -1.577 M | -1.794 M | |
Depreciation | 0.000 | 0.000 | 0.000 | 4.495 K | 0.000 | 0.000 | 0.000 | |
Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Investing Cashflow | -198.009 K | -48.409 K | 4.227 M | 235.402 K | 0.000 | 350.000 K | -1.250 M | |
Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Cash Change | -2.832 M | -2.977 M | 4.717 M | -5.546 M | -308.586 K | 25.468 K | 269.467 K |